This is an automated archive made by the Lemmit Bot.
The original was posted on /r/newzealand by /u/_Depths on 2024-09-11 23:57:37+00:00.
I have been asking Pharmac for updates on the potential funding of lisdexamphetamine (Vyvanse) for a while, and I received the email below.
This medication currently costs around $100 p/month, if it's even available. If you are one of the many thousands of New Zealanders diagnosed with ADHD, please have a look and provide feedback before October 3. Access to this medication should be for everyone, not only those who can afford it.
Tēnā koe
Pharmac is now consulting publicly on a proposal to fund lisdexamfetamine for the treatment of ADHD and to remove the renewal criteria for stimulant treatments - methylphenidate, dexamfetamine and modafinil.
I know this will be of interest to you and your networks, and I invite you to share this information so that as many people as possible are able to provide feedback. The feedback we receive is very important for the funding proposal we will take to Pharmac’s Board for a decision.
Consultation on the funding proposal for lisdexamfetamine opens on Thursday 12 September and closes on Thursday 26 September 2024. Consultation on the removal of the renewal criteria opens on Thursday 12 September and closes on Thursday 3 October 2024.
More information about Pharmac’s proposal, including how to provide feedback, is at:
- [Proposal to fund lisdexamfetamine for the treatment of ADHD]
- Link to Feedback Form
- Proposal to remove the renewal criteria for stimulant treatments
These proposals were developed following advice from clinicians and people living with ADHD. Pharmac is committed to funding medicines that help people live good, healthy lives with their whānau and communities.
After we have considered the feedback received in the public consultation, the funding proposal will go to Pharmac’s Board, or a delegate, for a decision. If approved, we expect that lisdexamfetamine will be available, and the renewal criteria will be removed, from 1 December 2024.
We will keep Pharmac’s website updated as the proposal progresses but if you have any questions, you are also welcome to contact us at [enquiry@pharmac.govt.nz](mailto:enquiry@pharmac.govt.nz).